MAPT and Cognitive impairment: Moreover, mice in which expression of O-GlcNAc transferase was knocked out in forebrain exhibit cognitive impairment, along with neurodegeneration and increased tau phosphorylation [502], suggesting that targeting of O-GlcNAcylation might represent an effective therapeutic strategy for tauopathy.